General Information of Drug (ID: DMS1PFA)

Drug Name
SB2
Synonyms
Antimony; 7440-36-0; Stibium metallicum; Antimony, metallic; UNII-9IT35J3UV3; Antymonowodor [Polish]; UNII-0VKZ97K3UB; 0VKZ97K3UB; Antimonwasserstoffes [German]; HSDB 785; 9IT35J3UV3; UN2676; Antymon; Antimonio; Antimoine; Antimony powder; MFCD00011211; Antimonyl citrate; Antimony, ion(Sb2+); Sb2+; stibanylidyne; Antimonide; Antymonowodor; Antimon; antimony atom; Antimony, citric acid complexes; antimony(0); Antimonwasserstoffes; EINECS 270-130-2; ANTIMONOUS HYDRIDE; ACMC-1BKT5; 51Sb; EC 231-146-5; AC1NS5Q0; Sb(0); ANT
Indication
Disease Entry ICD 11 Status REF
Plaque psoriasis EA90.0 Phase 3 [1]
Ankylosing spondylitis FA92.0 Application submitted [1]
Crohn disease DD70 Application submitted [1]
Psoriatic arthritis FA21 Application submitted [1]
Ulcerative colitis DD71 Application submitted [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
Sb
Canonical SMILES
[Sb]
InChI
1S/Sb
InChIKey
WATWJIUSRGPENY-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
5354495
ChEBI ID
CHEBI:30304
CAS Number
7440-36-0
TTD ID
D0CU1T
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)